Results 181 to 190 of about 38,866 (299)
Abstract Purpose Pregnancy induces significant changes in the body, including increased peripheral and choroidal blood perfusion and an increased systemic corticosteroid level. Here, we systematically reviewed the evidence on pregnancy as a risk factor for developing central serous chorioretinopathy (CSC) and conducted a meta‐analysis to obtain a ...
Nathalie Skovgaard Eriksen +15 more
wiley +1 more source
Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer. [PDF]
Kurabayashi A +5 more
europepmc +1 more source
Photodynamic Diagnosis and Therapy for Peritoneal Carcinomatosis from Gastrointestinal Cancers: Status, Opportunities, and Challenges. [PDF]
Kim HI, Wilson BC.
europepmc +1 more source
Photodynamic Diagnosis and Treatment for Atherosclerosis
Junichi Hayashi +2 more
openaire +2 more sources
Abstract Purpose To assess the risk of subretinal fluid (SRF) development in the fellow eye of chronic central serous chorioretinopathy (cCSC) patients with unilateral SRF at baseline. Methods Medical records of 334 presumed cCSC patients were retrospectively reviewed.
Helena M. A. Feenstra +4 more
wiley +1 more source
Focal therapy using a novel cooled laser device for prostate cancer: early trial results
Objectives To determine the short‐term oncological results and safety of the ProFocal Laser Therapy for Prostate Tissue Ablation (PFLT‐PC) trial, the first phase II clinical trial of ProFocal® (Medlogical Innovations, Sydney, Australia), a novel, cooled laser focal therapy (cLFT) device for prostate cancer (PCa) treatment. Patients and Methods Men with
Jonathan Kam +17 more
wiley +1 more source
Photodynamic Therapeutic Effect during 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumors. [PDF]
Nishimura N +13 more
europepmc +1 more source
Objective To assess the oncological outcomes of targeted microwave ablation (TMA) using organ‐based tracking (OBT) Fusion® via KOELIS Trinity® (KOELIS, Meylan, France) in men with intermediate‐risk prostate cancer (PCa): the VIOLETTE trial (ClinicalTrials.gov identifier: NCT04582656) Patients and Method In this prospective phase II, multicentre ...
Nicolas Barry Delongchamps +11 more
wiley +1 more source
Photodynamic Diagnosis-Guided Ureteroscopic Laser Ablation of Upper Urinary Tract Urothelial Carcinoma: Phase 2, Open-Label, Single-Arm Trial. [PDF]
Yoshida T +6 more
europepmc +1 more source
Photodynamic diagnosis and therapy in gynaecology
P. Hillemanns, P. Soergel
openaire +1 more source

